Previous Article | Next Article ![]()
Journal of Virology, April 2004, p. 4134-4144, Vol. 78, No. 8
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.8.4134-4144.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Christoph Seibert,2,
Pavel Pugach,1 Tom Ketas,1 Alexandra Trkola,3 Michael J. Endres,4,
Nicholas J. Murgolo,4 Elizabeth Coates,4 Gregory R. Reyes,4 Bahige M. Baroudy,4 Thomas P. Sakmar,2 John P. Moore,1* and Shawn E. Kuhmann1
Department of Microbiology and Immunology, Weill Medical College of Cornell University,1 Laboratory of Molecular Biology and Biochemistry, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10021,2 Division of Infectious Diseases, Department of Medicine, University Hospital Zurich, 8091 Zurich, Switzerland,3 Schering-Plough Research Institute, Kenilworth, New Jersey 070334
Received 23 July 2003/ Accepted 14 January 2004
AD101 and SCH-C are two chemically related small molecules that inhibit the entry of human immunodeficiency virus type 1 (HIV-1) via human CCR5. AD101 also inhibits HIV-1 entry via rhesus macaque CCR5, but SCH-C does not. Among the eight residues that differ between the human and macaque versions of the coreceptor, only one, methionine-198, accounts for the insensitivity of macaque CCR5 to inhibition by SCH-C. Thus, the macaque coreceptor engineered to contain the natural human CCR5 residue (isoleucine) at position 198 is sensitive to HIV-1 entry inhibition by SCH-C, whereas a human CCR5 mutant containing the corresponding macaque residue (methionine) is resistant. Position 198 is in CCR5 transmembrane (TM) helix 5 and is not located within the previously defined binding site for AD101 and SCH-C, which involves residues in TM helices 1, 2, 3, and 7. SCH-C binds to human CCR5 whether residue 198 is isoleucine or methionine, and it also binds to macaque CCR5. However, the binding of a conformation-dependent monoclonal antibody to human CCR5 is inhibited by SCH-C only when residue 198 is isoleucine. These observations, taken together, suggest that the antiviral effects of SCH-C and AD101 involve stabilization, or induction, of a CCR5 conformation that is not compatible with HIV-1 infection. However, SCH-C is unable to exert this effect on CCR5 conformation when residue 198 is methionine. The region of CCR5 near residue 198 has, therefore, an important influence on the conformational state of this receptor.
E.B. and C.S. contributed equally to this work.
Present address: Medarex, Inc., Bloomsbury, NJ 08804.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»